Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.

by GeneOnline
Share To

SEOUL, South Korea, March 23, 2023 /PRNewswire/ — CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri started from the Korean government project to combat new infectious diseases by the incumbent professor and MD of Hanyang University Emergency Medicine, Seoul.

PlaClin-M is a revolutionary disinfection device developed by CodeSteri of South Korea that helps protect people from the spread of new infectious diseases, viruses and bacteria, etc. The device uses advanced plasma technology to quickly and effectively disinfect any surface and space in a matter of minutes.

CodeSteri, with a $4.2M grant from the Korean government, developed ‘PlaClin’ after 5 years of R&D efforts with top experts in related fields commencing from 2015 when Mers hit Korea hard. PlaClin was awarded as an “Innovative Product” by the Ministry of Science and ICT and patented in USA and Korea.

The PlaClin solution is widely used by public sector agencies in Korea. The ambulances run by the government gained a big increase in operational effectiveness and cost savings by reducing the wait (reuse) time of Covid-19 carrying ambulances after disinfection from 1~2 hour to 10 to 20 minutes by switching to the PlaClin solution.

PlaClin-M is a compact and easy-to-use device that can be quickly utilised in any space.

With enhanced mobility and cordless convenience, the PlaClin-M is well suited for the disinfection of cruise ships, airplanes, trains, subways, etc. where space can be easily infected with crowded people and needs to be disinfected within a short time. Such airlines as Korean Airlines, Japan Airlines, and other major airlines can benefit a lot from using innovative PlaClin solutions. If PlaClin-M is used in the disinfection of airlines, they can save a huge time in reusing the planes and cost paying to airports by reducing the disinfection time by more than half. Major cruise lines such as Carnival, Royal Caribbean, Norwegian, etc. can enjoy mass infection-free operation with PlaClin-M. They can offer more safe travel environments to their customers and cost saving to themselves.

New infectious diseases with high mortality and contagiousness occur periodically at intervals of 3 to 4 years worldwide and are expected to repeat in the future as evidenced by Swine Flu 2009, Ebola 2013, Mers 2015, and Covid 2019. With the current saturated vaccination rate of Covid-19 and unscientific, time and labor-consuming disinfection globally, an innovative technology of PlaClin solutions well deserves attention from other governments and leading companies in the efforts to safeguard our environments from the pandemic.

PlaClin solution is eco-friendly disinfection harmless to both humans and devices, with FDA and CE certifications. It offers wide protection from cold, flu, food poisoning, and tuberculosis to high levels of sterilization in intensive care units, operating rooms, etc. “As a life-saving technology in the post Covid-19 era, the PlaClin-M is the essential device that provides safe and hygienic environments for workplaces and public spaces,” said Tae Ho Lim Ph.D., founder, and CEO of CodeSteri received 4 awards from ministers and 2 CES Innovation Awards. PlaClin-M is available now for purchase on CodeSteri and website.

JungChi Seo, PhD 
+82 10 5446 4996 

© All rights reserved. Collaborate with us:
Related Post
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
Should People Looking to Lose Weight Skip Sugar Substitutes?
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
A Close Look at the Evolution of ESG in Biopharma
Scientists Identified Potential New Drugs to Combat Blindness
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
The 2nd International Healthcare Week
Hong Kong , China
2023 ASCO annual meeting
Chicago, USA
BIO Asia-Taiwan 2023
Taipei, Taiwan
2023 Bio Asia Pacific
Bangkok, Thailand
Scroll to Top